-
公开(公告)号:US09988400B2
公开(公告)日:2018-06-05
申请号:US15094687
申请日:2016-04-08
Applicant: Genentech, Inc.
Inventor: Yu Jiang , Guosheng Wu , Po-Wai Yuen , Elisia Villemure , Jacob Schwarz , Cuong Ly , Benjamin Sellers , Matthew Volgraf
IPC: C07D513/04 , C07D513/10 , C07D513/14 , C07D519/00
CPC classification number: C07D513/14 , C07D513/04 , C07D513/10 , C07D519/00
Abstract: The present invention relates to certain thiazolopyrimidinone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US12202824B2
公开(公告)日:2025-01-21
申请号:US17816855
申请日:2022-08-02
Applicant: Genentech, Inc.
Inventor: Jack Alexander Terrett , Huifen Chen , Lea Constantineau-Forget , Robin Larouche-Gauthier , Luce Lépissier , Francis Beaumier , Martin Déry , Chantal Grand-Maître , Claudio Sturino , Matthew Volgraf , Elisia Villemure
IPC: C07D413/14 , A61K31/427 , A61K31/437 , A61K31/4375 , A61K31/4985 , A61K31/5025 , A61K31/519 , A61K31/522 , A61K31/53 , A61P11/00 , A61P19/02 , A61P23/00 , A61P25/00 , A61P29/00 , C07D471/04 , C07D473/08 , C07D473/30 , C07D487/04 , C07D498/04 , C07D513/04
Abstract: The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US10766878B2
公开(公告)日:2020-09-08
申请号:US16247995
申请日:2019-01-15
Applicant: Genentech, Inc.
Inventor: Baihua Hu , Vishal Verma , Matthew Volgraf , Anthony Estrada , Joseph Lyssikatos
IPC: C07D403/04 , C07D401/04 , C07D231/12 , C07D237/08 , C07D213/61 , C07D231/16 , C07D231/20 , C07D239/26
Abstract: The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US10647731B2
公开(公告)日:2020-05-12
申请号:US15962333
申请日:2018-04-25
Applicant: Genentech, Inc.
Inventor: Yu Jiang , Guosheng Wu , Po-Wai Yuen , Elisia Villemure , Jacob Schwarz , Cuong Ly , Benjamin Sellers , Matthew Volgraf
IPC: C07D513/14 , C07D513/04 , C07D513/10 , C07D519/00
Abstract: The present invention relates to certain thiazolopyrimidinone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US20200308161A1
公开(公告)日:2020-10-01
申请号:US16903020
申请日:2020-06-16
Applicant: Genentech, Inc.
Inventor: Jack Alexander Terrett , Huifen Chen , Lea Constantineau-Forget , Robin Larouche-Gauthier , Luce Lépissier , Francis Beaumier , Martin Déry , Chantal Grand-Maître , Claudio Sturino , Matthew Volgraf , Elisia Villemure
IPC: C07D413/14 , C07D473/30 , C07D471/04 , A61P29/00 , C07D513/04 , C07D487/04 , A61P25/00 , C07D498/04 , A61K31/427 , A61P23/00 , A61P11/00
Abstract: The invention relates to methods of using compounds formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US10711004B2
公开(公告)日:2020-07-14
申请号:US16558718
申请日:2019-09-03
Applicant: Genentech, Inc.
Inventor: Huifen Chen , Brian Safina , Daniel Shore , Jack Terrett , Elisia Villemure , Matthew Volgraf , Stuart Ward , Aijun Lu , Robin Larouche-Gauthier , Francis Beaumier , Martin Dery , Lea Constantineau-Forget , Chantal Grand-Maitre , Luce Lepissier
IPC: C07D473/30 , C07D471/04 , C07D487/04 , C07D473/08
Abstract: The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US10695348B2
公开(公告)日:2020-06-30
申请号:US16269973
申请日:2019-02-07
Applicant: Genentech, Inc.
Inventor: Vishal Verma , Matthew Volgraf , Baihua Hu
IPC: C07D401/02 , C07D401/12 , C07D401/14 , C07D515/04 , A61K31/506 , C07D491/048 , A61P11/00
Abstract: The invention provides compounds of formula I: and pharmaceutically acceptable salts thereof where R1 is a substituted or unsubstituted phenyl or a fused bicyclic comprising a substituted or unsubstituted phenyl. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US20180244694A1
公开(公告)日:2018-08-30
申请号:US15962333
申请日:2018-04-25
Applicant: Genentech, Inc.
Inventor: Yu Jiang , Guosheng Wu , Po-Wai Yuen , Elisia Villemure , Jacob Schwarz , Cuong Ly , Benjamin Sellers , Matthew Volgraf
IPC: C07D513/14 , C07D519/00 , C07D513/04 , C07D513/10
CPC classification number: C07D513/14 , C07D513/04 , C07D513/10 , C07D519/00
Abstract: The present invention relates to certain thiazolopyrimidinone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US12234245B2
公开(公告)日:2025-02-25
申请号:US17150349
申请日:2021-01-15
Applicant: Genentech, Inc.
Inventor: Christopher McBride , Lynnie Lin Trzoss , Amogh Boloor , Nadezda V. Sokolova , Richard M. Pastor , Steven Thomas Staben , Craig Stivala , Matthew Volgraf , Sarah M. Bronner
IPC: C07D498/04 , A61P31/04 , A61P31/12 , A61P31/14 , A61P31/16 , A61P31/18 , C07D231/18 , C07D471/04 , C07D487/04 , C07D513/04
Abstract: The present disclosure relates to novel sulfonimidamide compounds and related compounds and their use in treating a disorder responsive to modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
-
公开(公告)号:US11560391B2
公开(公告)日:2023-01-24
申请号:US17150380
申请日:2021-01-15
Applicant: Genentech, Inc.
Inventor: Jeffrey A. Stafford , James M. Veal , Lynnie Lin Trzoss , Christopher McBride , Richard M. Pastor , Steven Thomas Staben , Craig Stivala , Matthew Volgraf
IPC: C07D498/04
Abstract: The present disclosure relates to novel sulfonylurea compounds and related compounds useful in treating a disorder responsive to modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
-
-
-
-
-
-
-
-
-